(Q44045812)

29 November 2017

A reiterative method for calculating the early bactericidal activity of antituberculosis drugs (English)

1 reference

29 November 2017

2

Roland D Gosling

1 reference

29 November 2017

Stephen H Gillespie

1

1 reference

PubMed ID

12091167

29 November 2017

Bambos M Charalambous

series ordinal

3

1 reference

PubMed ID

12091167

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

29 November 2017

1 reference

29 November 2017

166

1 reference

29 November 2017

1

1 reference

29 November 2017

31-35

1 reference

USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results

29 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

A multicentre study of the early bactericidal activity of anti-tuberculosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. The DATRI 008 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

Early bactericidal activity of paromomycin (aminosidine) in patients with smear-positive pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

The action of antituberculosis drugs in short-course chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

Dormancy of Mycobacterium tuberculosis and latency of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

Sources of variation in studies of the early bactericidal activity of antituberculosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2112077

21 January 2018

Identifiers

DOI

10.1164/RCCM.2112077

1 reference

29 November 2017

1 reference

PubMed ID

12091167